StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.53−0.08 (-4.97%)

Close on Nov 18, 2026Market cap $3.59MP/E –Yield –

Xenetic Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Xenetic Biosciences

Xenetic Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Xenetic Biosciences figures

See a number that looks wrong?